Modulation of 8-Oxoguanine DNA Glycosylase 1 (OGG1) Alleviated Anemia Severity and Excessive Cytokines Release during Plasmodium berghei Malaria in Mice
-
Abdullahi Samaila
,
Rusliza Basir
,
Nur Aimi Liyana Abdul Aziz
,
Abdusalam Abdullah Alarabei
,
Mukhtar Lawal Gambo
,
Maizaton Atmadini Abdullah
,
Mohd Khairi Hussain
,
Norshariza Nordin
,
Roslaini Abd Majid
Abstract
Background: The interplay of OGG1, 8-Oxoguanine, and oxidative stress triggers the exaggerated release of cytokines during malaria, which worsens the outcome of the disease. We aimed to investigate the involvement of OGG1 in malaria and assess the effect of modulating its activity on the cytokine environment and anemia during P. berghei malaria in mice.
Methods: Plasmodium berghei ANKA infection in ICR mice was used as a malaria model. OGG1 concentration and oxidative stress levels in P. berghei-infected mice and their control counterparts were assessed during malaria using enzyme-linked immunosorbent assay. OGG1 activity in malaria mice was modulated using treatment with TH5487 and O8-OGG1 inhibitors. The effects of modulating OGG1 activity using OGG1 inhibitors on cytokine release and anemia during P. berghei malaria infection were assessed by cytometric bead array and measurement of total normal red blood cell count respectively.
Results: The plasma OGG1 level was significantly upregulated and positively correlated with parasitemia during P. berghei malaria in mice. Modulation of OGG1 ameliorated malaria severity by improving the total normal RBC count in TH5487 and O8-treated mice. Modulation of OGG1 with TH5487 caused significant reductions in serum levels of TNF-α, IFN-γ, IL-6, and IL-10. Similarly, OGG1 modulation activity using an O8-OGG1 inhibitor caused a significant reduction in serum levels of TNF-α, IL-2, IL-6, and IL-10.
Conclusion: The findings indicate the involvement of OGG1 in the P. berghei malaria infection. OGG1 inhibition by TH5487 and O8-OGG1 inhibitors suppressed excessive cytokine release, and this may represent a novel therapeutic strategy for ameliorating the severity of malaria infection.
2. Deroost K, Pham TT, Opdenakker G, Van den Steen PE. The immunological balance between host and parasite in malaria. FEMS Microbiol Rev. 2016; 40(2):208-57.
3. Gowda DC, Wu X. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria. Front Immunol. 2018; 9:3006.
4. Duque GA, Descoteaux A. Macrophage cytokines: Involvement in immunity and infectious diseases. Front Immunol. 2014; 5:491.
5. Dobbs KR, Crabtree JN, Dent AE. Innate immunity to malaria—The role of monocytes. Immunol Rev. 2020;293(1):8–24.
6. White NJ. Anaemia and malaria. Malar J. 2018;17(1):371.
7. Boulet C, Doerig CD, Carvalho TG. Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy? Front Cell Infect Microbiol. 2018;8:419.
8. Akanbi OM, Odaibo AB, Olatoregun R, Ademowo AB. Role of malaria induced oxidative stress on anaemia in pregnancy. Asian Pac J Trop Med. 2010;3(3):211–4.
9. Kavishe RA, Koenderink JB, Alifrangis M. Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons. FEBS J. 2017;284(16):2579–91.
10. Kay J, Thadhani E, Samson L EB (2019). Inflammation-Induced DNA Damage, Mutations and Cancer. DNA Repair (Amst). 2019;83:102673.
11. Vlahopoulos S, Adamaki M, Khoury N, Zoumpourlis V, Boldogh I. Roles of DNA repair enzyme OGG1 in innate immunity and its significance for lung cancer. Pharmacol Ther. 2019;194:59–72.
12. Tahara YK, Auld D, Ji D, et al. Potent and Selective Inhibitors of 8-Oxoguanine DNA Glycosylase. J Am Chem Soc. 2018;140(6):2105–2114.
13. Visnes T, Cázares-Körner A, Hao W, et al. Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation. Science. 2018; 362(6416):834-839.
14. Pan L, Zhu B, Hao W, et al. Oxidized guanine base lesions function in 8-oxoguanine DNA glycosylase-1-mediated epigenetic regulation of nuclear factor κB-driven gene expression. J Biol Chem. 2016;291(49):25553–66.
15. Ba X, Bacsi A, Luo J, et al. 8-oxoguanine DNA glycosylase-1 augments proinflammatory gene expression by facilitating the recruitment of site-specific transcription factors. J Immunol. 2014;192(5):2384-2394.
16. Aguilera-Aguirre L, Bacsi A, Radak Z, et al. Innate inflammation induced by the 8-oxoguanine DNA glycosylase-1-KRAS-NF-kappaB pathway. J Immunol. 2014;193(9):4643–4653.
17. Basir R, Rahiman SSF, Hasballah K, et al. Plasmodium berghei ANKA infection in ICR mice as a model of cerebral malaria. Iran J Parasitol. 2012;7(4):62–74.
18. Baig MA. Practical Guide to Clinical Haematology. NOTION PressINC, 2018; 2018. 392 p.
19. Zheng X, Wang K, Pan L, et al. Innate Immune Responses to RSV Infection Facilitated by OGG1, an Enzyme Repairing Oxidatively Modified DNA Base Lesions. J Innate Immun. 2022;14(6):593–614.
20. Huang H, Weaver A, Wu E, et al. Lipid-based signaling modulates dna repair response and survival against Klebsiella pneumoniae infection in host cells and in mice. Am J Respir Cell Mol Biol. 2013;49(5):798–807.
21. Hajnády Z, Nagy-Pénzes M, Demény MA, et al. OGG1 Inhibition Reduces Acinar Cell Injury in a Mouse Model of Acute Pancreatitis. Biomedicines. 2022;10(10): 2543.
22. Nsiah K, Bahaah B, Afranie BO, Acheampong E. Evaluation of red blood cell count as an ancillary index to hemoglobin level in defining the severe falciparum malarial anemia among Ghanaian children in low-resource communities. Heliyon. 2020;6(8):e04605.
23. Njewa B, Eyong EEJ, Ebai CB. Malaria parasitaemia and its impact on biological parameters among children <16 years old attending the Nkwen District Hospital, Cameroon. Malariaworld J. 2024;15:3.
24. Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: Insights for new treatments. Nat Med. 2013;19(2):156–67.
25. del Portillo HA, Ferrer M, Brugat T, Martin-Jaular L, Langhorne J, Lacerda MVG. The role of the spleen in malaria. Cell Microbiol. 2012;14(3):343–55.
26. Buffet PA, Safeukui I, Deplaine G, et al. The pathogenesis of Plasmodium falciparum malaria in humans: Insights from splenic physiology. Blood. 2011;117(2):381–92.
27. Cunnington AJ, Riley EM, Walther M. Stuck in a rut? Reconsidering the role of parasite sequestration in severe malaria syndromes. Trends Parasitol. 2013;29(12):585–92.
28. Chang KH, Stevenson MM. Malarial anaemia: Mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int J Parasitol. 2004;34(13–14):1501–16.
29. Awandare GA, Kempaiah P, Ochiel DO, Piazza P, Keller CC, Perkins DJ. Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model. Am J Hematol. 2011;86(2):155–62.
30. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–50.
31. Tracey KJ, Cerami A. Tumor necrosis factor: A pleiotropic cytokine and therapeu-tic target. Annu Rev Med. 1994;45:491–503.
32. Bayisa G, Dufera M. Malaria Infection, Parasitemia, and Hemoglobin Levels in Febrile Patients Attending Sibu Sire Health Facilities, Western Ethiopia. Biomed Res Int. 2022;2022: 6161410.
33. Hajnady Z, Nagy-Penzes M, Regdon Z, et al. Role of OGG1 in cerulein induced acute pancreatitis. FEBS OPEN BIO. 2021;11:492–3.
34. Donley N, Jaruga P, Coskun E, et al. Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1). ACS Chem Biol. 2015; 10(10):2334-43.
35. Langhorne J, Quin SJ, Sanni LA. Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol. 2002;80:204–28.
| Files | ||
| Issue | Vol 19 No 4 (2024) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijpa.v19i4.17163 | |
| Keywords | ||
| Malaria Plasmodium berghei Anaemia Cytokines | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
